<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to duloxetine (Cymbalta) for chronic pain - an SNRI antidepressant approved for multiple pain conditions.">
    <meta name="keywords" content="duloxetine, Cymbalta, SNRI pain, fibromyalgia medication, neuropathy medication, chronic pain antidepressant">
    <title>Duloxetine (Cymbalta) | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Duloxetine (Cymbalta)</h1><p>An SNRI for pain and depression</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Duloxetine?</h2>
                <p>Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that's FDA-approved for several chronic pain conditions as well as depression and anxiety. It affects neurotransmitters involved in both mood and pain perception.<sup>1</sup></p>

                <h2>FDA-Approved Pain Uses</h2>
                <ul>
                    <li>Fibromyalgia</li>
                    <li>Diabetic peripheral neuropathy</li>
                    <li>Chronic musculoskeletal pain</li>
                    <li>Also: depression, anxiety</li>
                </ul>

                <h2>How It Works<sup>2</sup></h2>
                <ul>
                    <li>Increases serotonin and norepinephrine</li>
                    <li>Enhances descending pain inhibition</li>
                    <li>Pain relief independent of mood effects</li>
                    <li>Takes 2-4 weeks to see benefit</li>
                </ul>

                <h2>Dosing</h2>
                <ul>
                    <li><strong>Start</strong>: 30 mg once daily</li>
                    <li><strong>Target</strong>: 60 mg once daily</li>
                    <li><strong>Maximum</strong>: 120 mg daily (some conditions)</li>
                    <li>Take at same time each day</li>
                    <li>Can take with or without food</li>
                </ul>

                <h2>Common Side Effects<sup>3</sup></h2>
                <ul>
                    <li>Nausea (often improves)</li>
                    <li>Dry mouth</li>
                    <li>Constipation</li>
                    <li>Fatigue or drowsiness</li>
                    <li>Dizziness</li>
                    <li>Decreased appetite</li>
                    <li>Sweating</li>
                    <li>Sexual dysfunction</li>
                </ul>

                <h2>Important Warnings</h2>
                <ul>
                    <li>Must taper off slowly (discontinuation syndrome)</li>
                    <li>Black box warning for suicidal thoughts in young adults</li>
                    <li>Avoid with MAOIs</li>
                    <li>Caution with liver disease</li>
                    <li>May increase blood pressure</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Dhaliwal JS, Spurling BC, Molla M. Duloxetine. In: StatPearls. StatPearls Publishing; 2023.</li>
                    <li>Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. <em>Cochrane Database Syst Rev</em>. 2014;(1):CD007115.</li>
                    <li>Pergolizzi JV, Raffa RB, Taylor R, et al. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. <em>Pain Pract</em>. 2013;13(3):239-252.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
